By integrating X-ray and γ-ray technologies, this platform enhances the vertex dose within the GTV while reducing doses to the GTV margins and OARs, offering a promising and feasible approach for the treatment of LRT in patients with large-volume lung tumors.
Gao et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: